Michael Aaron Pratt

Array ( [id] => 9280812 [patent_doc_number] => 20140030780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'METHODS AND ORGANISMS FOR THE GROWTH-COUPLED PRODUCTION OF 1,4-BUTANEDIOL' [patent_app_type] => utility [patent_app_number] => 13/914422 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 72849 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256277 [patent_doc_number] => 20150141274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'Methods and Compositions for Activity Dependent Transcriptome Profiling' [patent_app_type] => utility [patent_app_number] => 14/399057 [patent_app_country] => US [patent_app_date] => 2013-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38541 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10437426 [patent_doc_number] => 20150322439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'REPLICATIVE MINICIRCLE VECTORS WITH IMPROVED EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/442862 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21226 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814611 [patent_doc_number] => 20130115656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'ENGINEERED YEAST CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/665149 [patent_app_country] => US [patent_app_date] => 2012-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12262 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370623 [patent_doc_number] => 20120220011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/396403 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 49568 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301896 [patent_doc_number] => 20120184453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'BIOMARKERS FOR RECURRENCE PREDICTION OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/348098 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 12749 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13348098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335549 [patent_doc_number] => 20120202251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'IN VIVO ASSEMBLY OF DNA VIA HOMOLOGOUS RECOMBINATION' [patent_app_type] => utility [patent_app_number] => 13/282195 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16193 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055921 [patent_doc_number] => 20120077707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'MICROWELLS WITH MRI READABLE INDICIA' [patent_app_type] => utility [patent_app_number] => 13/241336 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1808 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077707.pdf [firstpage_image] =>[orig_patent_app_number] => 13241336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651789 [patent_doc_number] => 20110301058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => ' MICROFLUIDIC DEVICE' [patent_app_type] => utility [patent_app_number] => 13/156250 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5920 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301058.pdf [firstpage_image] =>[orig_patent_app_number] => 13156250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442257 [patent_doc_number] => 20120258873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'REDUCTION OF 2,3-DIHYDROXY-2-METHYL BUTYRATE (DHMB) IN BUTANOL PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/153866 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 34697 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12326895 [patent_doc_number] => 09944951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Chromosome 3p21.3 genes are tumor suppressors [patent_app_type] => utility [patent_app_number] => 13/114921 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 89 [patent_no_of_words] => 45612 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8397934 [patent_doc_number] => 08268309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Compositions and methods for the therapy and diagnosis of cytomegalovirus' [patent_app_type] => utility [patent_app_number] => 13/109632 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 35638 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586838 [patent_doc_number] => 20110281348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 13/107861 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29650 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281348.pdf [firstpage_image] =>[orig_patent_app_number] => 13107861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711015 [patent_doc_number] => 20120003671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS FOR ANTIBODY ENGINEERING' [patent_app_type] => utility [patent_app_number] => 13/100089 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15625 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13100089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491009 [patent_doc_number] => 20110237780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTI-INFLAMMATORY DAB' [patent_app_type] => utility [patent_app_number] => 13/008342 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7310 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237780.pdf [firstpage_image] =>[orig_patent_app_number] => 13008342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586382 [patent_doc_number] => 20110280892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/974953 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 64907 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280892.pdf [firstpage_image] =>[orig_patent_app_number] => 12974953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347793 [patent_doc_number] => 20120208718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/499672 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10918 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202399 [patent_doc_number] => 20110065185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS' [patent_app_type] => utility [patent_app_number] => 12/846625 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065185.pdf [firstpage_image] =>[orig_patent_app_number] => 12846625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268336 [patent_doc_number] => 20100298544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/797737 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 12792 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797737 [rel_patent_id] =>[rel_patent_doc_number] =>)